Publication not explained

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.

Featured Image

Read the Original

This page is a summary of: Letter by Imprialos et al Regarding Article, “Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation”, Circulation, July 2016, Wolters Kluwer Health,
DOI: 10.1161/circulationaha.116.022220.
You can read the full text:

Read

Contributors

The following have contributed to this page